<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04914234</url>
  </required_header>
  <id_info>
    <org_study_id>DTH: 21002</org_study_id>
    <nct_id>NCT04914234</nct_id>
  </id_info>
  <brief_title>Premedication With Atenolol Versus Metoprolol for Controlled Hypotensive Anesthesia During Nasal Surgeries</brief_title>
  <official_title>Premedication With Atenolol Versus Metoprolol for Controlled Hypotensive Anesthesia During Nasal Surgeries. A Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Damanhour Teaching Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Damanhour Teaching Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Objectives: To compare the safety and efficacy of oral atenolol versus oral metoprolol as a&#xD;
      premedication for controlled hypotensive anesthesia during nasal surgeries.&#xD;
&#xD;
      Background: Mucosal bleeding is the most frequent complication with nasal surgeries, as it&#xD;
      interferes with the optimal visualization of the intranasal anatomy, increases operation&#xD;
      time, and consequently increases blood loss. There are several pharmacological and&#xD;
      non-pharmacological techniques for the appropriate control of intraoperative bleeding.&#xD;
&#xD;
      Patients and Methods: This was a prospective, randomized, double-blind, phase four,&#xD;
      comparative clinical trial; carried out on 60 patients, who were candidates for nasal&#xD;
      surgeries under general anesthesia at our hospital. Patients were randomly allocated into two&#xD;
      equal groups; group A, received oral atenolol, and group M, received oral metoprolol.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 15, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 15, 2021</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mean and Standard deviation of Blood loss (ml)(mean±SD)</measure>
    <time_frame>5 minutes after the end of surgery</time_frame>
    <description>Amount of blood loss at the end of surgery</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Hypotension Drug-Induced</condition>
  <arm_group>
    <arm_group_label>Group A (n=30)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Atenolol group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group M (n=30)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Metoprolol group</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Atenolol Succinate Oral Tablet</intervention_name>
    <description>Atenolol 50 mg</description>
    <arm_group_label>Group A (n=30)</arm_group_label>
    <other_name>Tenormin tablets</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Metoprolol Succinate Oral Tablet</intervention_name>
    <description>Metoprolol 100 mg</description>
    <arm_group_label>Group M (n=30)</arm_group_label>
    <other_name>Seloken ZOC tablets</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  American Society of Anesthesiologists (ASA) physical status ≤ II&#xD;
&#xD;
          -  Age from 21 to 50 years&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  ASA physical status &gt; II&#xD;
&#xD;
          -  Age &lt; 21 years or &gt; 50 years&#xD;
&#xD;
          -  Pregnant women&#xD;
&#xD;
          -  Breastfeeding&#xD;
&#xD;
          -  Bronchial asthma&#xD;
&#xD;
          -  Chronic obstructive pulmonary disease&#xD;
&#xD;
          -  Diabetes Mellitus&#xD;
&#xD;
          -  Hypertension&#xD;
&#xD;
          -  Ischemic heart disease&#xD;
&#xD;
          -  Rheumatic heart disease&#xD;
&#xD;
          -  Heart failure&#xD;
&#xD;
          -  Heart block&#xD;
&#xD;
          -  Sick sinus syndrome&#xD;
&#xD;
          -  Sinus bradycardia&#xD;
&#xD;
          -  Chronic hypotension&#xD;
&#xD;
          -  Anemia (Hb &lt; 10 g/dl)&#xD;
&#xD;
          -  Renal or hepatic dysfunction&#xD;
&#xD;
          -  Central nervous system disease&#xD;
&#xD;
          -  Allergic fungal sinusitis&#xD;
&#xD;
          -  Patients on beta-blockers&#xD;
&#xD;
          -  Alcohol or drug abuse&#xD;
&#xD;
          -  Anticoagulation therapy,&#xD;
&#xD;
          -  Bleeding diathesis&#xD;
&#xD;
          -  Agents influencing autonomic nervous system&#xD;
&#xD;
          -  Allergy to the study drugs&#xD;
&#xD;
          -  Any contraindication of oral intake&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ahmed M Shaat, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Damanhour Teaching Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ahmed M Shaat, MD</last_name>
    <phone>00201223482709</phone>
    <email>ahmedshaat99@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Damanhour Teaching Hospital</name>
      <address>
        <city>Damanhūr</city>
        <state>El-Beheira</state>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ahmed M Shaat, MD</last_name>
      <phone>00201223482709</phone>
      <email>ahmedshaat99@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>May 31, 2021</study_first_submitted>
  <study_first_submitted_qc>May 31, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 4, 2021</study_first_posted>
  <last_update_submitted>October 8, 2021</last_update_submitted>
  <last_update_submitted_qc>October 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 11, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>atenolol</keyword>
  <keyword>controlled hypotension</keyword>
  <keyword>metoprolol</keyword>
  <keyword>nasal surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypotension</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Metoprolol</mesh_term>
    <mesh_term>Atenolol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

